Best Lung segmentectomy Lung segmentectomy in Israel: TOP 4 doctors

Prof. Merimsky leads the lung cancer service at Sourasky Medical Center, with extensive research and clinical focus on thoracic oncology.

• Over 41 years of experience of experience in oncology, specializing in lung and sarcoma cases
• Fellowship in soft tissue and bone sarcoma at Institut Gustave Roussy, Paris
• Member of IASLC and ESMO, contributing to lung cancer research and guidelines
• Published multiple studies on lung cancer treatment approaches

Leading expert in thoracic malignancies with a focus on lung cancer genomics and innovative treatments at Sourasky Medical Center.

• Senior lecturer at Tel Aviv University's Faculty of Medicine
• Primary investigator for multiple NSCLC clinical trials
• Moderator of the Israeli Lung Cancer Society's Molecular Tumor Board
• Specializes in comprehensive genomic profiling and liquid biopsies
• Recipient of ISCORT research grant and teaching honors

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.